Trademark Overview
On Wednesday, September 11, 2024, a trademark application was filed for AMLOGENYX with the United States Patent and Trademark Office. The USPTO has given the AMLOGENYX trademark a serial number of 98745222. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, March 21, 2025. This trademark is owned by Amlogenyx Inc.. The AMLOGENYX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases and disorders, neurological diseases and disorders, gene therapy, and cell therapy; biomedical research in the field of gene therapy design and delivery; new product design services in the field of gene therapy; product development of biochemical assays; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of neurological and genetic diseases and disorders; med...
